Therefore, the inactivation of HIF-1α is a hopeful approach for the development of new therapeutic modalities.8,17-19 Various investigators tried to find anti-cancer lead compounds with inhibitory effects against the accumulation of HIF-1 in the nucleus of hypoxic cells to overcome the hypoxia adaptation and also increase the sensitivity of cells to chemotherapy agents. The gene discussed is SETD2; the disease is cancer.